Comment from Kansas Board of Pharmacy on VA-2026-VHA-0166-0001
AnonymousOpposeGovernment
Summary: The Kansas State Board of Pharmacy opposes the proposed rule because it conflicts with state law, poses significant risks to patient privacy, and includes an unnecessary and overbroad federal preemption provision. While they support interstate data sharing, they argue the rule lacks sufficient oversight, fails to protect against unauthorized access, and requests a more narrowly tailored approach that preserves state regulatory authority.
The Kansas Board of Pharmacy respectfully submits the attached comments to the proposed rule.